Skip to main content
Mary Philip, MD, Oncology, Nashville, TN

Mary Philip MD PhD

Oncology•Nashville, TN

Hematologic Oncology

Assistant Professor Vanderbilt University School of Medicine

Join to view full profile

  • 3601 The Vanderbilt ClinicNashville, TN 37232

  • Phone+1 615-936-2000

  • Fax+1 615-936-7602

Dr. Philip is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Philip's full profileAlready have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2006 - 2011
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2004 - 2006
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2004

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2017 - 2026
  • WA State Medical License
    WA State Medical License 2006 - 2018
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion Stage
    Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion StageOctober 9th, 2024
  • Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion Stage
    Study Shows Cancer Vaccine Blocks Tumor Progression at Early Lesion StageOctober 7th, 2024
  • Study Identifies Critical Regulator of Tumor-Specific T Cell Differentiation
    Study Identifies Critical Regulator of Tumor-Specific T Cell DifferentiationJune 18th, 2019

Grant Support

  • TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunctionVANDERBILT UNIVERSITY MEDICAL CENTER2022–2027
  • TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunctionVANDERBILT UNIVERSITY MEDICAL CENTER2022–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Mary Philip, Dr. Mary Philip, MD, Dr. M Philip